<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The present study shows that systemic administration of the selective, non-competitive <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> <z:chebi fb="68" ids="48706">antagonist</z:chebi> MK-801 [(+)-5-<z:chebi fb="36" ids="29309">methyl</z:chebi>-10,11-dihydroxy-5H-dibenzo (a,d)-cyclohepten-5,10-<z:chebi fb="0" ids="24783">imine</z:chebi>] dose-dependently induces ipsiversive rotational behavior in the rats with a unilateral striatal lesion produced by transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> or in those with a unilateral nigrostriatal lesion produced by 6-hydroxydopamaine </plain></SENT>
<SENT sid="1" pm="."><plain>In relation to a functional model of the basal ganglia-thalamocortical 'motor' circuit, the present data suggest that the striatum may be one of the most important sites where MK-801 acts in the basal ganglia, with its being responsible for the <z:mp ids='MP_0001394'>circling</z:mp> behavior of the animal models </plain></SENT>
</text></document>